Orchid Pharma Board to Consider Fund Raising Options on 20th Oct'26
Orchid Pharma Ltd 路 Intimation 路 16 Oct 2026, 1:43 am
Orchid Pharma Board to Consider Fund Raising Options on 20th Oct'26 Orchid Pharma Limited has scheduled a Board of Directors meeting on 20th Oct'26 to evaluate multiple fund-raising avenues. Proposed structures include issuing equity shares, fully or partly convertible debentures, composite non-convertible debentures with warrants, or other eligible securities. The capital raise may occur via qualified institutional placement (QIP), preferential allotment, private placement, public issues, or alternative permissible modes, subject to requisite regulatory and shareholder approvals.
Original exchange filing (PDF)
More announcements from Orchid Pharma Ltd
- Audio Recording of the Analysts/Investors Earnings Call - Orchid Pharma Limited ('the Company') 路 18 Nov 2026
- Board Comments on fine levied by Stock Exchanges 路 17 Nov 2026
- Investor Presentation-Quarter II of FY 2026-27, ended on September 30, 2026 路 17 Nov 2026
- Statement of deviation or variation for the quarter ended on September 30, 2026 on the use of proceeds of funds raised through Qualified institutional placement (QIP) 路 14 Nov 2026
- Declaration of Financial results for quarter and half year ended on September 30, 2026 路 14 Nov 2026
- Outcome of Board Meeting 路 14 Nov 2026
- Orchid Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 14 Nov 2026
- Monitoring Agency Report for the Quarter-II ended on September 30, 2026 路 14 Nov 2026
